Value of Low-Density Lipoprotein Particle Number and Size as Predictors of Coronary Artery Disease in Apparently Healthy Men and Women

El Harchaoui, Karim, van der Steeg, Wim A., Stroes, Erik S.G., Kuivenhoven, Jan Albert, Otvos, James D., Wareham, Nicholas J., Hutten, Barbara A., Kastelein, John J.P. +2 more·2007·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2006.09.043

Cited by (239)

Items 101–200 of 239

Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy
Peter Paul Toth · 2012 · Vascular Health and Risk Management
Achieving Secondary Prevention Low-Density Lipoprotein Particle Concentration Goals Using Lipoprotein Cholesterol-Based Data
Simon C. Mathews, Jaya Reddy Mallidi, Krishnaji R. Kulkarni, Peter Paul Toth, Steven Richard Jones · 2012 · PLoS ONE
Estimation of the low-density lipoprotein (LDL) subclass phenotype using a direct, automated assay of small dense LDL-cholesterol without sample pretreatment
Annemie Vandermeersch, Sara Ameye, Dieter Puype, Dominique Petitjean, Marc De Buyzere, Michel R. Langlois · 2010 · Clinica Chimica Acta
Work and diet-related risk factors of cardiovascular diseases - comparison of two occupational groups
Danielle Hartung, Martina Stadeler, Romano Grieshaber, Sylvia Keller, Gerhard Jahreis · 2010 · Journal of Occupational Medicine and Toxicology
Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading?
Harold Edward Bays, Scott E. Conard, Lawrence A. Leiter, Steven R. Bird, Erin H. Jensen, Mary Elizabeth Hanson, Arvind Kumar Shah, Andrew M. Tershakovec · 2010 · Lipids in Health and Disease
There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3–5
Hsuan Chiu, Pei-Yu Wu, Jiun-Chi Huang, H. Tu, Ming-Yen Lin, Szu-Chia Chen, Jer-Ming Chang · 2020 · Scientific Reports
Measures of postprandial lipoproteins are not associated with coronary artery disease in patients with type 2 diabetes mellitus
Gissette Reyes‐Soffer, Steve Holleran, Wahida Karmally, Colleen I. Ngai, Niem-Tzu Chen, Margarita Torres, Rajasekhar Ramakrishnan, William S. Blaner, Lars Berglund, Henry N. Ginsberg et al. · 2009 · Journal of Lipid Research
Understanding hypertriglyceridemia in women: clinical impact and management with prescription omega-3-acid ethyl esters
Thomas D. Dayspring · 2011 · International Journal of Women s Health
Lipoprotein particles and size, total and high molecular weight adiponectin, and leptin in relation to incident coronary heart disease among severely obese postmenopausal women: The Women's Health Initiative Observational Study
Rachel H. Mackey, Kathleen M. McTigue, Yue‐Fang Chang, Emma Barinas‐Mitchell, Roger G. Evans, Lesley Fels Tinker, Cora Elizabeth Lewis, JoAnn E. Manson, Marcia L. Stefanick, Barbara V. Howard et al. · 2015 · BBA Clinical
Management of non-high-density lipoprotein abnormalities
Robert S. Rosenson · 2009 · Atherosclerosis
Value of Low-Density Lipoprotein Particle Number and Size as Predictors of Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population Study
Wm. James Howard · 2008 · Yearbook of Endocrinology
Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery disease
Tsuyoshi Nozue, Hiroaki Hattori, Kazuyuki Ogawa, Takeshi Kujiraoka, Tadao Iwasaki, Tsutomu Hirano, Ichiro Michishita · 2016 · Lipids in Health and Disease
Analysis of Lipoprotein Subfractions in Chinese Han Patients with Stable Coronary Artery Disease
Rui‐Xia Xu, Yan Zhang, Ping Ye, Hong Chen, Yanfang Li, Qi Hua, Yuan‐Lin Guo, Xiaolin Li, Sha Li, Qian Dong et al. · 2015 · Heart Lung and Circulation
Acute consumption of fish oil improves postprandial VLDL profiles in healthy men aged 50–65 years
Graham C. Burdge, Jonathan R. Powell, Tony Dadd, Duncan Talbot, Jacqueline Civil, Philip C. Calder · 2009 · British Journal Of Nutrition
A comparative study of four independent methods to measure LDL particle concentration
Paul Nathan Hopkins, James V. Pottala, M. Nazeem Nanjee · 2015 · Atherosclerosis
An increase in calculated small dense low-density lipoprotein cholesterol predicts new onset of hypertension in a Japanese cohort
Marenao Tanaka, Tatsuya Sato, Keisuke Endo, Masafumi Inyaku, Kazuma Mori, Itaru Hosaka, Takuma Mikami, Yukinori Akiyama, Hirofumi Ohnishi, Nagisa Hanawa et al. · 2023 · Hypertension Research
LDL particle size and number compared with LDL cholesterol and risk categorization in end-stage renal disease patients
Rodney G. Bowden, Ronald L. Wilson, A. Alexander Beaujean · 2011 · Journal of Nephrology
Which lipids should be analyzed for diagnostic workup and follow-up of patients with hyperlipidemias?
Langlois, Michel R., Nordestgaard, Børge G. · 2018 · Current Cardiology Reports
Hemoglobin level and lipoprotein particle size
Päivi Hämäläinen, Juha T Saltevo, Hannu Kautiainen, Pekka T Mäntyselkä, Mauno J. Vanhala · 2018 · Lipids in Health and Disease
Waist circumference, atherogenic lipoproteins, and vascular smooth muscle biomarkers in children.
S. Burns, S. Arslanian · 2009 · Journal of Clinical Endocrinology and Metabolism
Advanced Lipoprotein Testing: Recommendations Based on Current Evidence
Joe F. Lau, Donald Angehr Smith · 2009 · Endocrinology and Metabolism Clinics of North America
The Predictive Value of Atherogenic Index of Plasma, Non- High Density Lipoprotein Cholesterol (Non-HDL-C), Non-HDL-C/HDL-C, and Lipoprotein Combine Index for Stroke Incidence and Prognosis in Maintenance Hemodialysis Patients
Li-Jie Ma, Fang Sun, Kai-Yi Zhu, Qiuxia Han, Qian-Mei Sun · 2024 · Clinical Interventions in Aging
HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infection
Amber L. Wheeler, Rebecca Scherzer, Daniel Lee, Joseph A. Delaney, Peter Bacchetti, Michael G. Shlipak, Stephen Sidney, Carl Grünfeld, Phyllis C. Tien · 2013 · AIDS
Characterization of lipid profile by nuclear magnetic resonance spectroscopy (1H NMR) of metabolically healthy obese women after weight loss with Mediterranean diet and physical exercise
Enrique Rodríguez‐García, Josefina Ruiz-Nava, Sonia Santamaria-Fernández, José Carlos Fernández‐García, Antonio Vargas‐Candela, Raquel Yahyaoui, Francisco José Tinahones, María Rosa Bernal-López, Ricardo Gómez-Huelgas · 2017 · Medicine
Association of low-density lipoprotein pattern with mortality after myocardial infarction: Insights from the TRIUMPH study
Yashashwi Pokharel, Yuanyuan Tang, Bhaskar Bhardwaj, Krishna Patel, Mohammed Qintar, James Henry O’Keefe, Krishnaji R. Kulkarni, Peter H. Jones, Seth Shay Martin, Salim S. Virani et al. · 2017 · Journal of clinical lipidology
Associations of Genetic Variants in ATP-Binding Cassette A1 and Cholesteryl Ester Transfer Protein and Differences in Lipoprotein Subclasses in the Multi-Ethnic Study of Atherosclerosis
Michael Y. Tsai, Na Li, A. Richey Sharrett, Steven Shea, David R. Jacobs, Russell P. Tracy, Donna K. Arnett, Valerie L. Arends, Wendy S. Post · 2009 · Clinical Chemistry
Macrovascular Complications of Diabetes Mellitus
Donald S. Nuzum, Tonja Merz · 2009 · Journal of Pharmacy Practice
The U-shaped association of non-high-density lipoprotein cholesterol with all-cause and cardiovascular mortality in general adult population
Yu Huang, Meng Qi Yan, Dan Zhou, Chao Lei Chen, Yingqing Feng · 2023 · Frontiers in Cardiovascular Medicine
Superiority of lipoprotein particle number to detect associations with arterial thickness and stiffness in obese youth with and without prediabetes
AMY SANGHAVI SHAH, William Sean Davidson, Zhiqian Gao, Lawrence M. Dolan, Thomas R. Kimball, Elaine M. Urbina · 2016 · Journal of clinical lipidology
Ruminant-Produced trans-Fatty Acids Raise Plasma Total and Small HDL Particle Concentrations in Male Hartley Guinea Pigs ,
Beth H. Rice, Jana Kraft, Frédéric Destaillats, Dale Elton Bauman, A.L. Lock · 2010 · Journal of Nutrition
Advanced Atherogenic Index for the Assessment of Consolidated Lipid Risk in Premature Coronary Artery Disease Patients in India
Sanjiv Kumar Bansal, Sarita Agarwal, Daga Mk · 2016 · Journal of Laboratory Physicians
Prognostic Importance of Systemic Endotoxinemia Indicators in Atherogenesis
Д.П. Покусаева, Irina A. Anikhovskaya, Л.А. Коробкова, Г. Г. Энукидзе, M. Yu. Yakovlev · 2019 · Human Physiology
The benefits of measuring the size and number of lipoprotein particles for cardiovascular risk prediction: A systematic review and meta-analysis
José A. Quesada, Vicente Bertomeu‐González, Domingo Orozco‐Beltrán, Alberto Cordero, Vicente Francisco Gil-Guillén, Adriana López‐Pineda, Rauf Nouni-García, Concepción Carratalá‐Munuera · 2022 · Clínica e Investigación en Arteriosclerosis
Cardiovascular Disease Risk Factors Other than Dyslipidemia
Tamio Teramoto, Junichi Sasaki, Shun Ishibashi, Sadatoshi Birou, Hiroyuki Daida, Seitaro Dohi, Genshi Egusa, Takafumi Hiro, Kazuhiko Hirobe, Mami Iida et al. · 2013 · Journal of Atherosclerosis and Thrombosis
Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial
Ruben N. Eppinga, Minke H.T. Hartman, Dirk Jan van Veldhuisen, Chris P. H. Lexis, Margery A. Connelly, Erik Lipšic, Iwan C.C. van der Horst, Pim van der Harst, Robin P. F. Dullaart · 2016 · PLoS ONE
Low-density lipoprotein 4: a novel predictor of coronary artery disease severity
Rahul Chaudhary, Denny P. Mathew, Kevin P. Bliden, Udaya S. Tantry, Tushar Sharma, Martin G. Gesheff, Christopher J. Franzese, Shachi Pandya, Peter Paul Toth, Paul Alfred Gurbel · 2017 · Current Medical Research and Opinion
Lipoprotein profiles of fat distribution and its association with insulin sensitivity
Dongmei Wei, Vannina G. Marrachelli, Jesús D. Melgarejo, Chia‐Te Liao, Stefan P. Janssens, Peter B. Verhamme, Thomas Vanassche, Lucas N. L. Van Aelst, Daniel Monleón, Josep Redón et al. · 2022 · Frontiers in Endocrinology
HIV, HAART, and lipoprotein particle concentrations in the Women's Interagency HIV Study
Phyllis C. Tien, Michael F. Schneider, Christopher Cox, Mardge H. Cohen, Roksana Karim, Jason Lazar, Mary Young, Marshall Jay Glesby · 2010 · AIDS
Changes in Lipoprotein Particle Number With Ezetimibe/Simvastatin Coadministered With Extended‐Release Niacin in Hyperlipidemic Patients
Ngoc‐Anh Le, Ran Jin, Joanne E. Tomassini, Andrew M. Tershakovec, David Neff, Peter W.F. Wilson · 2013 · Journal of the American Heart Association
Biomarker Discovery in Atherosclerotic Diseases Using Quantitative Nuclear Magnetic Resonance Metabolomics
Shuai Ma, Mingfeng Xia, Xin Gao · 2021 · Frontiers in Cardiovascular Medicine
NMR-determined lipoprotein subclass profile is associated with dietary composition and body size☆
Allison M. Hodge, Alicia Josephine Jenkins, Dallas R. English, Kerin O’Dea, Graham G. Giles · 2010 · Nutrition Metabolism and Cardiovascular Diseases
NMR analysis of lipoprotein particle size does not increase sensitivity to the effect of soy protein on CVD risk when compared with the traditional lipid profile
Antonio S. Santo, Ariana M. Cunningham, Sofiya Alhassan, Richard W. Browne, Harold Burton, John J. Leddy, Peter W. Grandjean, Steven M. Horvath, Peter J. Horvath · 2008 · Applied Physiology, Nutrition, and Metabolism
Quantitative and qualitative effects of rosuvastatin on LDL-cholesterol: what is the clinical significance?
Manfredi Rizzo, Kaspar K. Berneis, Giatgen A. Spinas, Giovam Battista Rini, Navin Kumar Kapur · 2009 · International Journal of Clinical Practice
Impact of short‐term low‐dose atorvastatin on low‐density lipoprotein and high‐density lipoprotein subfraction phenotype
Rui‐Xia Xu, Yuan‐Lin Guo, Xiaolin Li, Sha Li, Jian‐Jun Li · 2014 · Clinical and Experimental Pharmacology and Physiology
Beneficial Effects of Rosuvastatin Treatment in Patients With Metabolic Syndrome
Cem Bostan, Ahmet Yıldız, Alev Arat Özkan, Işıl Uzunhasan, Ayşem Kaya, Zerrin Yiğit · 2014 · Angiology
Managing to low-density lipoprotein particles compared with low-density lipoprotein cholesterol: A cost-effectiveness analysis
John A. Rizzo, Peter J. Mallow, Heidi C. Waters, Gregory S. Pokrywka · 2013 · Journal of clinical lipidology
Hypertriglyceridaemia, Postprandial Lipaemia and Non-HDL Cholesterol
Claudia Stefanutti, Giancarlo Labbadia, Vasilios Gabriel Athyros · 2014 · Current Pharmaceutical Design
Analysis of LDL and HDL size and number by nuclear magnetic resonance in a healthy working population: The LipoLab Study
Vicente Pallarés‐Carratalá, José A. Quesada, Domingo Orozco‐Beltrán, Núria Amigó, Adriana López‐Pineda, Antonio Fernández Giménez, Vicente Francisco Gil-Guillén, Xavier Correig, L. Masana, Daniel Monleón et al. · 2020 · International Journal of Clinical Practice
Dyslipidemia and Cardiovascular Disease
Hossein Fakhrzadeh, Ozra Tabatabaei‐Malazy · 2012 · InTech eBooks
Low-density lipoprotein cholesterol to apolipoprotein B ratio is independently associated with metabolic syndrome in Korean men
Chang Hee Kwon, Byung Jin Kim, Bum Soo Kim, Jin Ho Kang · 2011 · Metabolism
Effects of Pitavastatin on Lipoprotein Subfractions and Oxidized Low-density Lipoprotein in Patients with Atherosclerosis
Rui‐Xia Xu, Yan Zhang, Yue Zhang, Yaru Wu, Xiaolin Li, Yuan‐Lin Guo, Geng Liu, Qian Dong, Jian‐Jun Li · 2020 · Current Medical Science
Relation of long-term body weight change to change in lipoprotein particle size in Japanese men and women: The INTERMAP Toyama Study
Rie Naganuma, Masaru Sakurai, Katsuyuki Miura, Katsushi Yoshita, Yuko Morikawa, Teruhiko Kido, Hirotsugu Ueshima, Hideaki Nakagawa, Jeremiah Stamler · 2009 · Atherosclerosis
Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus
Ronald B Goldberg, Robert S. Rosenson, Eric Hernández-Triana, Soamnauth Misir, Michael R. Jones · 2012 · Journal of clinical lipidology
Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy
Peter Paul Toth, William Insull, Robert J. Padley, Rhea Angela N Parreño, Ping X. Jiang, Thakkar, Scott L. Krause, H. Robert Superko · 2010 · Vascular Health and Risk Management
Effectiveness of 2 Methods of Promoting Physical Activity, Healthy Eating, and Emotional Well-Being With the Americans in Motion--Healthy Interventions Approach
Wilson D. Pace, Angela M Lanigan, Elizabeth W. Staton, D. G. Graham, Brian K. Manning, L. Miriam Dickinson, Caroline Bublitz Emsermann, Elizabeth E Stewart · 2013 · The Annals of Family Medicine
A comparison of lipid and lipoprotein measurements in the fasting and nonfasting states in patients with type 2 diabetes
Kathleen Marie Dungan, Tia Guster, Darren A. DeWalt, John B. Buse · 2007 · Current Medical Research and Opinion
Effects of atorvastatin 10 mg and fenofibrate 200 mg on the low-density lipoprotein profile in dyslipidemic patients: A 12-week, multicenter, randomized, open-label, parallel-group study
Jean-Claude Ansquer, Christophe Corda, Karine Le Malicot, Valerie Jessent · 2009 · Current Therapeutic Research
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
Sammy Chan, GB John Mancini, Andrew P. Ignaszewski, Jiri J Frohlich · 2008 · BMC Clinical Pharmacology
Lipoprotein particle profiles by nuclear magnetic resonance spectroscopy in medically underserved HIV-infected persons
Barbara A. Swanson, Beverly E. Sha, Joyce K. Keithley, Louis Fogg, Judith L. Nerad, Richard M. Novak, Oluwatoyin M Adeyemi · 2009 · Journal of clinical lipidology
Two-Hour Postprandial Lipoprotein Particle Concentration Differs Between Lean and Obese Individuals
Ehsan Parvaresh Rizi, Sonia Baig, Tze Ping Loh, Sue-Anne Ee Shiow Toh, Chin Meng Khoo, E Shyong Tai · 2019 · Frontiers in Physiology
Impact of improved low-density lipoprotein cholesterol assessment on guideline classification in the modern treatment era—Results from a racially diverse Brazilian cross-sectional study
Vincent A. Pallazola, Vasanth Sathiyakumar, Oluseye Ogunmoroti, Oluwaseun E. Fashanu, Steven Richard Jones, Raul Dias Santos, Peter Paul Toth, Márcio Sommer Bittencourt, Bruce Bartholow Duncan, Paulo A. Lotufo et al. · 2019 · Journal of clinical lipidology
Association of height and pubertal timing with lipoprotein subclass profile: Exploring the role of genetic and environmental effects
Aline Jelenkovic, Leonie Helen Bogl, Richard J. Rose, Antti J. Kangas, Pasi Soininen, Mika Ala‐Korpela, Jaakko A. Kaprio, Karri Silventoinen · 2013 · American Journal of Human Biology
Linking diabetes and atherosclerosis
Riccardo Candido, Stella Bernardi, Terri J. Allen · 2009 · Expert Review of Endocrinology & Metabolism
Ruminant-Produced trans-Fatty Acids Raise Plasma HDL Particle Concentrations in Intact and Ovariectomized Female Hartley Guinea Pigs
Beth H. Rice, Jana Kraft, Frédéric Destaillats, Dale Elton Bauman, A.L. Lock · 2012 · Journal of Nutrition
Effect of Dielectric Barrier Discharge Treatment of Blood Plasma to Improve Rheological Properties of Blood
Jin Mu Jung, Yong Yang, Dong Hoon Lee, Gregory Fridman, Alexander Fridman, Young I. Cho · 2011 · Plasma Chemistry and Plasma Processing
The genetic architecture of lipoprotein subclasses in Gullah-speaking African American families enriched for type 2 diabetes: The Sea Islands Genetic African American Registry (Project SuGAR)
Jasmin Divers, M. Sale, Ling-Yi Lu, Wei-Min Chen, Kerry H. Lok, Ida J. Spruill, J. Fernandes, Carl D. Langefeld, W. Garvey · 2010 · Journal of Lipid Research
Lipoprotein Subclasses Independently Contribute to Subclinical Variance of Microvascular and Macrovascular Health
Lukas Streese, Hansjörg Habisch, Arne Deiseroth, Justin Carrard, Denis Infanger, Arno Schmidt‐Trucksäss, Tobias Madl, Henner Hanssen · 2022 · Molecules
Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study
Sang-He-On Suh, Tae Ryom Oh, Hong-Sang Choi, C. Kim, E. Bae, S. Ma, K. Oh, S. Han, S. Kim · 2022 · Nutrients
Evaluation of small dense low‐density lipoprotein concentration for predicting the risk of acute coronary syndrome in Chinese population
Bin Wu, Zhiwu Yu, Tong Tong, Xinxin Tong, Yinmei Yang, Yongcai Tang, Huiming Ren, Yike Liao, Jun Liao · 2019 · Journal of Clinical Laboratory Analysis
Review article: the impact of liver‐directed therapies on the atherogenic risk profile in non‐alcoholic steatohepatitis
Margery A. Connelly, Jonathan Velez Rivera, John R. Guyton, Mohammad Shadab Siddiqui, Arun Jayant Sanyal · 2020 · Alimentary Pharmacology & Therapeutics
Targeting Residual Risk: The Rationale for the Use of Non-HDL Cholesterol
Venkata Mahesh Alla, Manu Kaushik, Aryan N. Mooss · 2010 · Southern Medical Journal
Combined Dyslipidemia in Children and Adolescents
Rae-Ellen Webb Kavey · 2016
Triglycerides/High density lipoprotein cholesterol ratio as a cardiometabolic risk marker in children and adolescents from Mérida city, Venezuela
Miguel Aguirre, Yajaira Briceño, Roald Gómez‐Pérez, Yajaira Zerpa, Nolis Irene Camacho, Mariela Paoli · 2018 · Endocrinología Diabetes y Nutrición (English ed )
Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among Racially Diverse Populations
Kui Deng, Xiong‐Fei Pan, Markus Voehler, Qiuyin Cai, Hui Cai, Xiao‐Ou Shu, Deepak K. Gupta, Loren P. Lipworth, Wei Zheng, Danxia Yu · 2024 · Journal of the American Heart Association
Colesevelam improved lipoprotein particle subclasses in patients with prediabetes and primary hyperlipidaemia
Ronald B Goldberg, Robert S. Rosenson, Eric Hernández-Triana, Soamnauth Misir, Michael R. Jones · 2012 · Diabetes and Vascular Disease Research
Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients
Marcelino Bermúdez-López, Hèctor Perpiñán, Núria Amigó, Eva Castro, Núria Alonso, Dı́dac Mauricio, Elvira Fernández, José Manuel Valdivielso · 2021 · Clinical Kidney Journal
Perspective: A potential role for NUS in metabolite‐based in vitro diagnostics
Leslie Hoyt, Elizabeth M. O’Day · 2020 · Magnetic Resonance in Chemistry
Cardiovascular risk profile in Caribbean youth with diabetes mellitus.
Marshall Kerr Tulloch-Reid, Michael S. Boyne, M F Smikle, Eric G. Choo-Kang, R H Parkes, R Wright-Pascoe, EN Barton, RJ Wilks, Desmond E. Williams · 2009 · PubMed
Effect of Colesevelam HCl Monotherapy on Lipid Particles in Type 2 Diabetes Mellitus
Robert S. Rosenson, Scott P. Rigby, Michael R. Jones, Hubert S. Chou · 2014 · Cardiovascular Drugs and Therapy
Increased monocyte to HDL cholesterol ratio in vitamin B12 deficiency: Is it related to cardiometabolic risk?
Sanem Kayhan, Nazlı Gülsoy Kirnap, Mercan Taştemur · 2020 · International Journal for Vitamin and Nutrition Research
Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markers
Cathy Sun, Diane Brisson, Daniel Gaudet, Teik Chye Ooi · 2020 · Journal of clinical lipidology
Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease
Rui‐Xia Xu, Yan Zhang, Xiaolin Li, Sha Li, Yuan‐Lin Guo, Qian Dong, Geng Liu, Jian‐Jun Li · 2015 · Clinica Chimica Acta
New insights in preventive cardiology and cardiac rehabilitation
Barry A. Franklin, Justin E. Trivax, Thomas E. Vanhecke · 2008 · Current Opinion in Cardiology
Apolipoprotein B outperforms low density lipoprotein particle number as a marker of cardiovascular risk in the UK Biobank
Elizabeth Epstein, Eson Ekpo, Doug Evans, Elsa B. Varughese, Melody Hermel, Sheila Jeschke, Sharjeel Hassan, Ali Torkamani, Evan D. Muse, Douglas W. Triffon · 2025 · European Journal of Preventive Cardiology
Effect of Exercise Training on Lipoprotein Subclass Particle Concentrations and Sizes in Older Women: Results from a Randomized Controlled Trial
Ryan R. Porter, Joshua R. Sparks, John Larry Durstine, Sabra Custer, Raymond W. Thompson, Xuewen Wang · 2023 · Geriatrics
Evidence that Low Density Lipoprotein Is the Primary Cause of Atherosclerotic Cardiovascular Disease: A Bradford-Hill Approach
David S. Schade, Deborah Helitzer, Philip Eaton · 2017 · World Journal of Cardiovascular Diseases
The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A
Duo Zuo, Haohua An, Jianhua Li, Jiawei Xiao, Li Ren · 2021 · Journal of Personalized Medicine
Are Additional Lipid Measures Useful?
Ryan D. Bradley, Erica B. Oberg · 2008 · PubMed
Foundation/American Heart Association Task Force on Practice Guidelines Asymptomatic Adults : A Report of the American College of Cardiology 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in
Sidney C. Smith, Allen J. Taylor, William S. Weintraub, Frederick G. Kushner, Michael S. Lauer, J. Malvern Benjamin, Matthew Jay Budoff, Zahi Adel Fayad, Elyse Foster, Philip Greenland et al. · 2011
Association of a cholesteryl ester transfer protein variant (rs1800777) with fat mass, HDL cholesterol levels, and metabolic syndrome
Daniel Antonio de Luis, Olatz Izaola, David Primo, Emilia Gómez Hoyos, Juan José López Gómez, Ana Ortolá, R. Aller · 2018 · Endocrinología Diabetes y Nutrición
Hypertriglyceridemia in Youth
Don P. Wilson, Lauren Hough Williams, Rae-Ellen Webb Kavey · 2021 · The Journal of Pediatrics
Ongoing challenges for pharmacotherapy for dyslipidemia
Anthony David Pisaniello, Daniel J Scherer, Yu Kataoka, Stephen James Nicholls · 2014 · Expert Opinion on Pharmacotherapy
Establishing reference intervals for triglyceride-containing lipoprotein subfraction metabolites measured using nuclear magnetic resonance spectroscopy in a UK population
Roshni Joshi, S. Goya Wannamethee, Jorgen Engmann, Tom R. Gaunt, Debbie A. Lawlor, Jackie F. Price, Olia Papacosta, Tina Shah, Therese Tillin, Peter Hynes Whincup et al. · 2020 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
Relación triglicéridos/colesterol de la lipoproteína de alta densidad como indicador de riesgo cardiometabólico en niños y adolescentes de la ciudad de Mérida, Venezuela
Miguel Aguirre, Yajaira Briceño, Roald Gómez‐Pérez, Yajaira Zerpa, Nolis Irene Camacho, Mariela Paoli · 2017 · Endocrinología Diabetes y Nutrición
Moving beyond LDL-C: incorporating lipoprotein particle numbers and geometric parameters to improve clinical outcomes
Thomas D. Dayspring, Dall, Abuhajir · 2010 · Research Reports in Clinical Cardiology
We Must Prevent Disease, Not Predict Events⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
Allan D. Sniderman · 2008 · Journal of the American College of Cardiology
Physical Activity, Exercise, and Lipids and Lipoproteins
John Larry Durstine, Elizabeth Anderson, Ryan R. Porter, Xuewen Wang · 2019 · Springer eBooks
LDL-C or apoB as the best target for reducingcoronary heart disease: should apoB be implemented into clinical practice?
H Vaverková · 2011 · Clinical Lipidology
Is combination therapy an effective way of reaching lipid goals in Type 2 diabetes mellitus?
Yehuda Handelsman, Vivian Andrew Fonseca, Julio Rosenstock · 2011 · Expert Review of Clinical Pharmacology
Lipoprotein subclasses—A changing landscape
Michael Y. Tsai, Jing Cao · 2008 · Current Cardiovascular Risk Reports